GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...

This Fool considers how two low-risk and well-established FTSE shares could offer stability and growth during a period of ...

Advancements in non-opioid therapies, AI-integrated solutions, and regenerative medicine drive transformative growth in the pain management market. AUSTIN, TX, UNITED STATES, January 21, 2025 ...

Pfizer Inc. (NYSE:PFE) has announced the sale of shares worth £2.50 billion ($3.05 billion) in British consumer healthcare giant Haleon, reducing its ownership stake to 7.3% from 15%. The transaction ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares closed today ...

Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core pharmaceutical operations.

Shares in the maker of Sensodyne, Panadol and Advil ... which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019. It was spun off from the British drugmaker ...

A dip in inflation today eased pressure on Rachel Reeves and boosted hopes of a February interest rate cut. On the corporate front, Currys has raising profits guidance alongside a strong festive ...

The sale of 700 million Haleon shares at 357 pence apiece is a discount of about 2.8% to the stock's closing price on Tuesday ...

Panadol and Advil painkillers, and Centrum vitamins. Pfizer is a New York-based pharmaceutical and biotechnology firm. Haleon was formed in 2019 as a joint venture of Pfizer and GSK PLC's consumer ...

Haleon--which owns brands such as Sensodyne toothpaste, Aquafresh mouthwash and over-the-counter medicines Panadol and Advil--was formed in July 2019 through the merger of GSK and Pfizer's ...